# Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients

> **NCT00857532** · PHASE2 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 31 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** florbetapir F 18

## Key facts

- **NCT ID:** NCT00857532
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2013-03-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00857532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00857532, "Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00857532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*